Ivermectin clinical trials
Letter to the Editor
The Ivermectin clinical trials, denied by our Government.
The US medical research group Front Line COVID-19 Critical Care Alliance, cites 27 controlled trials involving a total of 6612 patients that “have been completed using well-matched control groups”; 16 trials involving over 2500 patients, “that are prospective, randomized, controlled studies”. Eleven of the 27 Ivermectin trials published in peer-reviewed journals involved 3900 patients. See the attached PDF file.
In Australia, leading medical professor Thomas Borody, who developed a globally successful therapy for peptic ulcer, announced a triple therapy off-label ivermectin-based treatment for COVID-19 in August 2020. His work was ignored by state and federal health authorities who simply continued to beat the vaccine drum.
His data shows ivermectin can not only prevent but knock out COVID infections within a few days.
OK, that’s good, but now:-
Read the text below, to find out how our Fed Health Department is “keeping Australians safe”
THE TEXT BELOW IS A TRANSCRIPT FROM THE .GOV WEBSITE AS AT 18th May, 2021
Find out how we are using evidence in our approach to COVID-19 treatments to keep Australians safe.
The Australian Government is closely monitoring worldwide research into COVID-19 treatments.
Ivermectin, doxycycline, zinc
There is currently insufficient evidence to support the safe and effective use of ivermectin, doxycycline and zinc (either separately, or in combination) for the prevention or treatment of COVID-19. More robust, well-designed clinical trials are needed before they could be considered an appropriate treatment option.
The National COVID-19 Clinical Evidence Taskforce, consisting of a large group of clinical experts, is continuously updating treatment recommendations based on the best available evidence. They have not made any recommendations for the use of ivermectin, doxycycline or zinc outside of properly conducted clinical trials with appropriate ethical approval.”
So our National COVID-19 Clinical Evidence Taskforce is looking for “more robust, well-designed clinical trials.” Well, here they are, in the public domain. Read the attached PDF file.
This information is sufficient evidence for action regarding the statement on their website that “The Australian Government is closely monitoring worldwide research into COVID-19 treatments.”
Well, here they are, all listed in the attached PDF file, all in the public domain.
Of course, the Taskforce do not say whether or not they will actually do anything with any new research!
Monitoring does not mean a change of outlook.
from David Blake